logo

Global Human Vaccines Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

Region:Global

Product Code:MR55992

Download Sample Report
Published On

October 2020

Total pages

110

About the Report

The Human Vaccines market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Human Vaccines market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Human Vaccines market. The report focuses on well-known providers in the global Human Vaccines industry, market segments, competition, and the macro environment.
 
Under COVID-19 Outbreak, how the Human Vaccines Industry will develop is also analyzed in detail in Chapter 1.7 of the report.
In Chapter 2.4, we analyzed industry trends in the context of COVID-19.
In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.
In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.
In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.
 
A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.
 
Key players in the global Human Vaccines market covered in Chapter 4:
Takeda Pharmaceutical Company Limited.
Bavarian Nordic
GlaxoSmithKline plc
Novartis AG
Pfizer, Inc.
Mymetics
Shenzhen Kangtai Biological Products Co., Ltd.
Emergent BioSolutions, Inc.
Johnson & Johnson
Bharat Biotech
Merck & Co., Inc.
CSL Limited
AstraZeneca
Sanofi
 
In Chapter 11 and 13.3, on the basis of types, the Human Vaccines market from 2015 to 2026 is primarily split into:
Pneumococcal
Influenza
Hepatitis
HPV
Meningococcal
Rotavirus
Measles
Typhoid
Combination
 
In Chapter 12 and 13.4, on the basis of applications, the Human Vaccines market from 2015 to 2026 covers:
Pediatrics
Adolescents
Adults
Geriatrics
 
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:
North America (Covered in Chapter 6 and 13)
United States
Canada
Mexico
Europe (Covered in Chapter 7 and 13)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8 and 13)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 9 and 13)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 10 and 13)
Brazil
Argentina
Columbia
Chile
Others
 
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2026

Scope of the Report

Products

The Human Vaccines market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period.

Table of Contents

Table of Content

 

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Regulatory Scenario by Region/Country

1.4 Market Investment Scenario Strategic

1.5 Market Analysis by Type

1.5.1 Global Human Vaccines Market Share by Type (2020-2026)

1.5.2 Pneumococcal

1.5.3 Influenza

1.5.4 Hepatitis

1.5.5 HPV

1.5.6 Meningococcal

1.5.7 Rotavirus

1.5.8 Measles

1.5.9 Typhoid

1.5.10 Combination

1.6 Market by Application

1.6.1 Global Human Vaccines Market Share by Application (2020-2026)

1.6.2 Pediatrics

1.6.3 Adolescents

1.6.4 Adults

1.6.5 Geriatrics

1.7 Human Vaccines Industry Development Trends under COVID-19 Outbreak

1.7.1 Global COVID-19 Status Overview

1.7.2 Influence of COVID-19 Outbreak on Human Vaccines Industry Development

 

2. Global Market Growth Trends

2.1 Industry Trends

2.1.1 SWOT Analysis

2.1.2 PorteraEURs Five Forces Analysis

2.2 Potential Market and Growth Potential Analysis

2.3 Industry News and Policies by Regions

2.3.1 Industry News

2.3.2 Industry Policies

2.4 Industry Trends Under COVID-19

 

3 Value Chain of Human Vaccines Market

3.1 Value Chain Status

3.2 Human Vaccines Manufacturing Cost Structure Analysis

3.2.1 Production Process Analysis

3.2.2 Manufacturing Cost Structure of Human Vaccines

3.2.3 Labor Cost of Human Vaccines

3.2.3.1 Labor Cost of Human Vaccines Under COVID-19

3.3 Sales and Marketing Model Analysis

3.4 Downstream Major Customer Analysis (by Region)

3.5 Value Chain Status Under COVID-19

 

4 Players Profiles

4.1 Takeda Pharmaceutical Company Limited.

4.1.1 Takeda Pharmaceutical Company Limited. Basic Information

4.1.2 Human Vaccines Product Profiles, Application and Specification

4.1.3 Takeda Pharmaceutical Company Limited. Human Vaccines Market Performance (2015-2020)

4.1.4 Takeda Pharmaceutical Company Limited. Business Overview

4.2 Bavarian Nordic

4.2.1 Bavarian Nordic Basic Information

4.2.2 Human Vaccines Product Profiles, Application and Specification

4.2.3 Bavarian Nordic Human Vaccines Market Performance (2015-2020)

4.2.4 Bavarian Nordic Business Overview

4.3 GlaxoSmithKline plc

4.3.1 GlaxoSmithKline plc Basic Information

4.3.2 Human Vaccines Product Profiles, Application and Specification

4.3.3 GlaxoSmithKline plc Human Vaccines Market Performance (2015-2020)

4.3.4 GlaxoSmithKline plc Business Overview

4.4 Novartis AG

4.4.1 Novartis AG Basic Information

4.4.2 Human Vaccines Product Profiles, Application and Specification

4.4.3 Novartis AG Human Vaccines Market Performance (2015-2020)

4.4.4 Novartis AG Business Overview

4.5 Pfizer, Inc.

4.5.1 Pfizer, Inc. Basic Information

4.5.2 Human Vaccines Product Profiles, Application and Specification

4.5.3 Pfizer, Inc. Human Vaccines Market Performance (2015-2020)

4.5.4 Pfizer, Inc. Business Overview

4.6 Mymetics

4.6.1 Mymetics Basic Information

4.6.2 Human Vaccines Product Profiles, Application and Specification

4.6.3 Mymetics Human Vaccines Market Performance (2015-2020)

4.6.4 Mymetics Business Overview

4.7 Shenzhen Kangtai Biological Products Co., Ltd.

4.7.1 Shenzhen Kangtai Biological Products Co., Ltd. Basic Information

4.7.2 Human Vaccines Product Profiles, Application and Specification

4.7.3 Shenzhen Kangtai Biological Products Co., Ltd. Human Vaccines Market Performance (2015-2020)

4.7.4 Shenzhen Kangtai Biological Products Co., Ltd. Business Overview

4.8 Emergent BioSolutions, Inc.

4.8.1 Emergent BioSolutions, Inc. Basic Information

4.8.2 Human Vaccines Product Profiles, Application and Specification

4.8.3 Emergent BioSolutions, Inc. Human Vaccines Market Performance (2015-2020)

4.8.4 Emergent BioSolutions, Inc. Business Overview

4.9 Johnson & Johnson

4.9.1 Johnson & Johnson Basic Information

4.9.2 Human Vaccines Product Profiles, Application and Specification

4.9.3 Johnson & Johnson Human Vaccines Market Performance (2015-2020)

4.9.4 Johnson & Johnson Business Overview

4.10 Bharat Biotech

4.10.1 Bharat Biotech Basic Information

4.10.2 Human Vaccines Product Profiles, Application and Specification

4.10.3 Bharat Biotech Human Vaccines Market Performance (2015-2020)

4.10.4 Bharat Biotech Business Overview

4.11 Merck & Co., Inc.

4.11.1 Merck & Co., Inc. Basic Information

4.11.2 Human Vaccines Product Profiles, Application and Specification

4.11.3 Merck & Co., Inc. Human Vaccines Market Performance (2015-2020)

4.11.4 Merck & Co., Inc. Business Overview

4.12 CSL Limited

4.12.1 CSL Limited Basic Information

4.12.2 Human Vaccines Product Profiles, Application and Specification

4.12.3 CSL Limited Human Vaccines Market Performance (2015-2020)

4.12.4 CSL Limited Business Overview

4.13 AstraZeneca

4.13.1 AstraZeneca Basic Information

4.13.2 Human Vaccines Product Profiles, Application and Specification

4.13.3 AstraZeneca Human Vaccines Market Performance (2015-2020)

4.13.4 AstraZeneca Business Overview

4.14 Sanofi

4.14.1 Sanofi Basic Information

4.14.2 Human Vaccines Product Profiles, Application and Specification

4.14.3 Sanofi Human Vaccines Market Performance (2015-2020)

4.14.4 Sanofi Business Overview

 

5 Global Human Vaccines Market Analysis by Regions

5.1 Global Human Vaccines Sales, Revenue and Market Share by Regions

5.1.1 Global Human Vaccines Sales by Regions (2015-2020)

5.1.2 Global Human Vaccines Revenue by Regions (2015-2020)

5.2 North America Human Vaccines Sales and Growth Rate (2015-2020)

5.3 Europe Human Vaccines Sales and Growth Rate (2015-2020)

5.4 Asia-Pacific Human Vaccines Sales and Growth Rate (2015-2020)

5.5 Middle East and Africa Human Vaccines Sales and Growth Rate (2015-2020)

5.6 South America Human Vaccines Sales and Growth Rate (2015-2020)

 

6 North America Human Vaccines Market Analysis by Countries

6.1 North America Human Vaccines Sales, Revenue and Market Share by Countries

6.1.1 North America Human Vaccines Sales by Countries (2015-2020)

6.1.2 North America Human Vaccines Revenue by Countries (2015-2020)

6.1.3 North America Human Vaccines Market Under COVID-19

6.2 United States Human Vaccines Sales and Growth Rate (2015-2020)

6.2.1 United States Human Vaccines Market Under COVID-19

6.3 Canada Human Vaccines Sales and Growth Rate (2015-2020)

6.4 Mexico Human Vaccines Sales and Growth Rate (2015-2020)

 

7 Europe Human Vaccines Market Analysis by Countries

7.1 Europe Human Vaccines Sales, Revenue and Market Share by Countries

7.1.1 Europe Human Vaccines Sales by Countries (2015-2020)

7.1.2 Europe Human Vaccines Revenue by Countries (2015-2020)

7.1.3 Europe Human Vaccines Market Under COVID-19

7.2 Germany Human Vaccines Sales and Growth Rate (2015-2020)

7.2.1 Germany Human Vaccines Market Under COVID-19

7.3 UK Human Vaccines Sales and Growth Rate (2015-2020)

7.3.1 UK Human Vaccines Market Under COVID-19

7.4 France Human Vaccines Sales and Growth Rate (2015-2020)

7.4.1 France Human Vaccines Market Under COVID-19

7.5 Italy Human Vaccines Sales and Growth Rate (2015-2020)

7.5.1 Italy Human Vaccines Market Under COVID-19

7.6 Spain Human Vaccines Sales and Growth Rate (2015-2020)

7.6.1 Spain Human Vaccines Market Under COVID-19

7.7 Russia Human Vaccines Sales and Growth Rate (2015-2020)

7.7.1 Russia Human Vaccines Market Under COVID-19

 

8 Asia-Pacific Human Vaccines Market Analysis by Countries

8.1 Asia-Pacific Human Vaccines Sales, Revenue and Market Share by Countries

8.1.1 Asia-Pacific Human Vaccines Sales by Countries (2015-2020)

8.1.2 Asia-Pacific Human Vaccines Revenue by Countries (2015-2020)

8.1.3 Asia-Pacific Human Vaccines Market Under COVID-19

8.2 China Human Vaccines Sales and Growth Rate (2015-2020)

8.2.1 China Human Vaccines Market Under COVID-19

8.3 Japan Human Vaccines Sales and Growth Rate (2015-2020)

8.3.1 Japan Human Vaccines Market Under COVID-19

8.4 South Korea Human Vaccines Sales and Growth Rate (2015-2020)

8.4.1 South Korea Human Vaccines Market Under COVID-19

8.5 Australia Human Vaccines Sales and Growth Rate (2015-2020)

8.6 India Human Vaccines Sales and Growth Rate (2015-2020)

8.6.1 India Human Vaccines Market Under COVID-19

8.7 Southeast Asia Human Vaccines Sales and Growth Rate (2015-2020)

8.7.1 Southeast Asia Human Vaccines Market Under COVID-19

 

9 Middle East and Africa Human Vaccines Market Analysis by Countries

9.1 Middle East and Africa Human Vaccines Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Human Vaccines Sales by Countries (2015-2020)

9.1.2 Middle East and Africa Human Vaccines Revenue by Countries (2015-2020)

9.1.3 Middle East and Africa Human Vaccines Market Under COVID-19

9.2 Saudi Arabia Human Vaccines Sales and Growth Rate (2015-2020)

9.3 UAE Human Vaccines Sales and Growth Rate (2015-2020)

9.4 Egypt Human Vaccines Sales and Growth Rate (2015-2020)

9.5 Nigeria Human Vaccines Sales and Growth Rate (2015-2020)

9.6 South Africa Human Vaccines Sales and Growth Rate (2015-2020)

 

10 South America Human Vaccines Market Analysis by Countries

10.1 South America Human Vaccines Sales, Revenue and Market Share by Countries

10.1.1 South America Human Vaccines Sales by Countries (2015-2020)

10.1.2 South America Human Vaccines Revenue by Countries (2015-2020)

10.1.3 South America Human Vaccines Market Under COVID-19

10.2 Brazil Human Vaccines Sales and Growth Rate (2015-2020)

10.2.1 Brazil Human Vaccines Market Under COVID-19

10.3 Argentina Human Vaccines Sales and Growth Rate (2015-2020)

10.4 Columbia Human Vaccines Sales and Growth Rate (2015-2020)

10.5 Chile Human Vaccines Sales and Growth Rate (2015-2020)

 

11 Global Human Vaccines Market Segment by Types

11.1 Global Human Vaccines Sales, Revenue and Market Share by Types (2015-2020)

11.1.1 Global Human Vaccines Sales and Market Share by Types (2015-2020)

11.1.2 Global Human Vaccines Revenue and Market Share by Types (2015-2020)

11.2 Pneumococcal Sales and Price (2015-2020)

11.3 Influenza Sales and Price (2015-2020)

11.4 Hepatitis Sales and Price (2015-2020)

11.5 HPV Sales and Price (2015-2020)

11.6 Meningococcal Sales and Price (2015-2020)

11.7 Rotavirus Sales and Price (2015-2020)

11.8 Measles Sales and Price (2015-2020)

11.9 Typhoid Sales and Price (2015-2020)

11.10 Combination Sales and Price (2015-2020)

 

12 Global Human Vaccines Market Segment by Applications

12.1 Global Human Vaccines Sales, Revenue and Market Share by Applications (2015-2020)

12.1.1 Global Human Vaccines Sales and Market Share by Applications (2015-2020)

12.1.2 Global Human Vaccines Revenue and Market Share by Applications (2015-2020)

12.2 Pediatrics Sales, Revenue and Growth Rate (2015-2020)

12.3 Adolescents Sales, Revenue and Growth Rate (2015-2020)

12.4 Adults Sales, Revenue and Growth Rate (2015-2020)

12.5 Geriatrics Sales, Revenue and Growth Rate (2015-2020)

 

13 Human Vaccines Market Forecast by Regions (2020-2026)

13.1 Global Human Vaccines Sales, Revenue and Growth Rate (2020-2026)

13.2 Human Vaccines Market Forecast by Regions (2020-2026)

13.2.1 North America Human Vaccines Market Forecast (2020-2026)

13.2.2 Europe Human Vaccines Market Forecast (2020-2026)

13.2.3 Asia-Pacific Human Vaccines Market Forecast (2020-2026)

13.2.4 Middle East and Africa Human Vaccines Market Forecast (2020-2026)

13.2.5 South America Human Vaccines Market Forecast (2020-2026)

13.3 Human Vaccines Market Forecast by Types (2020-2026)

13.4 Human Vaccines Market Forecast by Applications (2020-2026)

13.5 Human Vaccines Market Forecast Under COVID-19

 

14 Appendix

14.1 Methodology

14.2 Research Data Source

 

Research Methodology

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022